Circulating oxidized low-density lipoprotein and paraoxonase activity in preeclampsia

Gynecologic and Obstetric Investigation

Volumn 60, Issue 4, 2005, Pages 195-200

  Uzun, H ^a,c   Benian, A ^a   Madazli, R ^a   Topcuoglu M A ^b   Aydin, S ^a   Albayrak, M ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Malondialdehyde; Oxidized low density lipoprotein; Paraoxonase; Preeclampsia

Indexed keywords

ARYLDIALKYLPHOSPHATASE; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; OXIDIZED LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LIPID ANALYSIS; PATHOPHYSIOLOGY; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; SPECTROPHOTOMETRY;

ADULT; ANTIOXIDANTS; ARYLDIALKYLPHOSPHATASE; FEMALE; HUMANS; LIPOPROTEINS; LIPOPROTEINS, LDL; MALONDIALDEHYDE; PRE-ECLAMPSIA; PREGNANCY; TRIGLYCERIDES;

EID: 27644569628     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000087205     Document Type: Article

References (36)

1. Roberts JM, Cooper DW: Pathogenesis and genetics of pre-eclampsia. Lancet 2001;357:53-56.
2. Redman CW, Sargent IL: The pathogenesis of pre-eclampsia. Gynecol Obstet Fertil 2001;29:518-522.
3. Hubel CA: Oxidative stress in the pathogenesis of preeclampsia. Proc Soc Exp Biol Med 1999;222:222-235.
4. Orhan H, Önderoglu L, Yücel A, Sahin G: Circulating biomarkers of oxidative stress in complicated pregnancies. Arch Gynecol Obstet 2003;267:189-195.
5. Kumar CA, Das UN: Oxidant stress in preeclampsia and eesential hypertension. J Assoc Physicians India 2002;50:1372-1375.
6. Gurer OH, Özgüneş H, Beksaç MS: Correlation between plasma malondialdehyde and ceruloplasmin activity values in preeclamptic pregnancies. Clin Biochem 2000;34:505-506.
7. Kumar CA, Das UN: Lipid peroxides, antioxidants and nitric oxide in patients with preeclampsia and essential hypertension. Med Sci Monit 2000;6:901-907.
8. Steinberg D: Oxidative modification of LDL and atherogenesis. Circulation 1997;95:1062-1071.
9. Li D, Mehta JL: 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors protect against oxidized low-density lipoprotein induced endothelial dysfunction. Endothelium 2003;10:17-21.
10. Bonnefont-Rousselot D, Therond P, Beaudeux JL, Peynet J, Legrand A, Delattre J: High density lipoproteins (HDL) and oxidative hypothesis of atherosclerosis. Clin Chem Lab Med 1999;37:938-948.
11. Roberts JM, Lain KY: Recent insights into the pathogenesis of pre-eclampsia. Placenta 2002;23:359-372.
12. Mackness MI, Mackness B, Durrington PN, Connelly PW, Hegele RA: Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins. Curr Opin Lipidol 1996;7:69-76.
13. Masse J, Giguere Y, Kharfi A, Girouard J, Forest JC: Pathophysiology and maternal biologic markers of preeclampsia. Endocrine 2002;19:113-125.
14. American College of Obstetricians and Gynecologists: Hypertension in pregnancy. ACOG Tech Bull 1996;219:1-8.
15. Buege JA, Aust SD: Microsomal lipid peroxidation. Methods Enzymol 1978;52:302-310.
16. Hasselwander O, Savage DA, McMaster D, Loughrey CM, McNamee PT, Middleton D, Nicholls DP, Maxwell AP, Young IS: Paraoxonase polymorphisms are not associated with cardiovascular risk in renal transplants recipients. Kidney Int 1999;56:289-298.
17. Saha N, Roy AC, Teo SH, Tay JS, Ratnam SS: Influence of serum paraoxonase polymorphism on serum lipids and apolipoproteins. Clin Genet 1991;40:277-282.
18. Ness RB, Roberts JM: Heterogenous causes constituting the single syndrome of pre-eclampsia, a hypothesis and in implications. Am J Obstet Gynecol 1996;175:1365-1370.
19. Madazli R, Benian A, Gümüştaş K, Uzun H, Ocak V, Aksu F: Lipid peroxidation and anti-oxidant in preeclampsia. Eur J Obstet Gynecol Reprod Biol 1999;85:205-208.
20. McCord JM: The evolution of free radicals and oxidative stress. Am J Med 2000;108:652-659.
21. Mackness MI, Mackness B, Durrington PN: Paraoxonase and coronary heart disease. Atheroscler Suppl 2002;3:49-55.
22. Mackness B, Durrington PN, Mackness MI: Polymorphisms of paraoxonase genes and low-density lipoprotein lipid peroxidation. Lancet 1999;353:468-469.
23. Mackness MI, Arrol S, Mackness B, Durrington PN: Alloenzymes of paraoxonase and effectiveness of high-density lipoproteins in protecting low-density lipoprotein against lipid peroxidation. Lancet 1997;349:851-852.
24. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Habel CA, McLaughlin MK: Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1990;163:1365-1366.
25. McCarthy AL, Woolfson RG, Raju SK, Poston L: Abnormal endothelial cell function of resistance arteries from women with preeclampsia. Am J Obstet Gynecol 1993;168:1323-1330.
26. Uddin M, Yang H, Shi M, Polley-Mandal M, Guo Z: Elevation of oxidative stress in the aorta of genetically hypertensive mice. Mech Ageing Dev 2003;124:811-817.
27. Somova LI, Nadar A, Gregory M, Khan N: Antioxidant status of the hypertrophic heart of Dahl hypertensive rat as a model for evaluation of antioxidant. Methods Find Exp Clin Pharmacol 2001;23:5-12.
28. Williams MA, Woelk GB, King IB, Jenkins L, Mahomed K: Plasma carotenoids, retinol, tocopherols and lipoproteins in preeclamptic and normotensive pregnant Zimbabwean woman. Am J Hypertens 2003;16:665-672.
29. Ware-Jauregui S, Sanchez SE, Zhang C, Laraburre G, King IB, Williams MA: Plasma lipid concentrations in pre-eclampsia and normotensive Peruvian women. Int J Gynecol Obstet 1999;67:147-155.
30. Gratacos E, Casals E, Gömez O, Llurba E, Mercader I, Cararach V, Cabero L: Increased susceptibility to low density lipoprotein oxidation in women a history of pre-eclampsia. Int J Obstet Gynecol 2003;110:400-404.
31. Branch DW, Mitchell MD, Miller E, Palinski W, Witztum JL: Preeclampsia and serum anti-bodies to oxidised low-density lipoprotein. Lancet 1994;343:645-646.
32. Saǧol S, Özkinay E, Özşener S: Impaired anti-oxidant activity in women with pre-eclampsia. Int J Gynecol Obstet 1999;64:121-127.
33. Mertens A, Holvoet P: Oxidized LDL and HDL: antagonists in atherothrombosis. FASEB J 2001;15:2073-2084.
34. Durrington PN, Mackness B, Mackness MI: Paraoxanase and atherosclerosis. Atherosclor Thromb Vasc Biol 2001;21:473-480.
35. Jarvik GP, Tsai NT, McKinstry LA, Wani R, Brophy VH, Richter RJ, Schellenberg GD, Heagerty PJ, Hatsukami TS, Furlong CE: Vitamin C and E intake associated with increased paraoxonase activity. Arterioscler Thromb Vasc Biol 2002;22:1329-1333.
36. Kumru S, Aydin S, Gursu MF, Ozcan Z: Changes of serum paraoxonase (an HDL-cholesterol-associated lipophilic antioxidant) and arylesterase activities in severe preeclamptic women. Eur J Obstet Gynecol Reprod Biol 2004;114:177-181.